Lenvatinib inhibition of EMT in ICC cells
Lenvatinib enhanced AZGP1 activity through H3K27Ac modification and inhibited the downstream TGF-β1/Smad3 signaling pathway.
Publication
AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway (2023) Liming Deng, et al. Cell Death Dis. 2023 Sep;14(9):590. Figure: F7.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | AZGP1 | AZGP1 | ncbigene_symbol | AZGP1 | 563 |
| Homo sapiens | Primates | TGF-B1 | TGF-B1 | ncbigene_synonym | TGFB1 | 7040 |
| Homo sapiens | Primates | SMAD3 | SMAD3 | ncbigene_symbol | SMAD3 | 4088 |
| Homo sapiens | Primates | [E-cadherin] | CDH1 | ncbigene_symbol | CDH1 | 999 |
| Homo sapiens | Primates | [E-cadherin] | CDH1 | ncbigene_synonym | FZR1 | 51343 |
| Homo sapiens | Primates | [N-cadherin] | CDH2 | ncbigene_symbol | CDH2 | 1000 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Lenvatinib | lenvatinib | 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide | chebi:85994 | |
| Lenvatinib | lenvatinib | 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide | chebi:85994 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|